25 XP   0   0   10

Bionano Genomics Inc
Buy, Hold or Sell?

Let's analyse Bionano together

PenkeI guess you are interested in Bionano Genomics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Bionano Genomics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Bionano Genomics Inc

I send you an email if I find something interesting about Bionano Genomics Inc.

Quick analysis of Bionano (30 sec.)










What can you expect buying and holding a share of Bionano? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.76
Expected worth in 1 year
$-1.04
How sure are you?
20.7%

+ What do you gain per year?

Total Gains per Share
$-2.80
Return On Investment
-252.4%

For what price can you sell your share?

Current Price per Share
$1.11
Expected price per share
$1 - $1.35
How sure are you?
50%

1. Valuation of Bionano (5 min.)




Live pricePrice per Share (EOD)

$1.11

Intrinsic Value Per Share

$-38.65 - $-45.68

Total Value Per Share

$-36.89 - $-43.92

2. Growth of Bionano (5 min.)




Is Bionano growing?

Current yearPrevious yearGrowGrow %
How rich?$96.1m$281.7m-$116.4m-70.4%

How much money is Bionano making?

Current yearPrevious yearGrowGrow %
Making money-$58.1m-$33.1m-$24.9m-43.0%
Net Profit Margin-641.8%-479.8%--

How much money comes from the company's main activities?

3. Financial Health of Bionano (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

What can you expect buying and holding a share of Bionano? (5 min.)

Welcome investor! Bionano's management wants to use your money to grow the business. In return you get a share of Bionano.

What can you expect buying and holding a share of Bionano?

First you should know what it really means to hold a share of Bionano. And how you can make/lose money.

Speculation

The Price per Share of Bionano is $1.11. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bionano.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bionano, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.76. Based on the TTM, the Book Value Change Per Share is $-0.70 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bionano.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.80-72.3%-1.06-95.7%-0.61-54.6%-0.46-41.9%-0.36-32.3%
Usd Book Value Change Per Share-0.42-37.6%-0.70-63.1%-0.40-36.1%0.087.1%0.065.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.42-37.6%-0.70-63.1%-0.40-36.1%0.087.1%0.065.5%
Usd Price Per Share1.89-1.66-1.81-2.56-2.22-
Price to Earnings Ratio-0.59--0.40--0.77--2.40--2.80-
Price-to-Total Gains Ratio-4.53--2.91--11.05--12.40--13.55-
Price to Book Ratio1.08-0.72-0.35--1.56-0.88-
Price-to-Total Gains Ratio-4.53--2.91--11.05--12.40--13.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.11
Number of shares900
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.700.08
Usd Total Gains Per Share-0.700.08
Gains per Quarter (900 shares)-630.4070.77
Gains per Year (900 shares)-2,521.61283.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2522-25320283273
20-5043-50540566556
30-7565-75760849839
40-10086-10098011321122
50-12608-12620014151405
60-15130-15142016991688
70-17651-17664019821971
80-20173-20186022652254
90-22694-22708025482537
100-25216-25230028312820

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.028.00.03.4%1.028.00.03.4%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%6.020.03.020.7%6.020.03.020.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%6.020.03.020.7%6.020.03.020.7%

Fundamentals of Bionano

About Bionano Genomics Inc

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-03-20 12:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Bionano Genomics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Bionano earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of -409.4% means that $-4.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bionano Genomics Inc:

  • The MRQ is -409.4%. The company is making a huge loss. -2
  • The TTM is -641.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-409.4%TTM-641.8%+232.4%
TTM-641.8%YOY-479.8%-162.0%
TTM-641.8%5Y-487.2%-154.6%
5Y-487.2%10Y-403.4%-83.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-409.4%6.2%-415.6%
TTM-641.8%7.4%-649.2%
YOY-479.8%8.0%-487.8%
5Y-487.2%7.1%-494.3%
10Y-403.4%7.7%-411.1%
1.1.2. Return on Assets

Shows how efficient Bionano is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • -20.5% Return on Assets means that Bionano generated $-0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bionano Genomics Inc:

  • The MRQ is -20.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.5%TTM-27.3%+6.9%
TTM-27.3%YOY-10.3%-17.1%
TTM-27.3%5Y-20.8%-6.5%
5Y-20.8%10Y-27.7%+6.9%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.5%1.2%-21.7%
TTM-27.3%1.2%-28.5%
YOY-10.3%1.7%-12.0%
5Y-20.8%1.6%-22.4%
10Y-27.7%1.6%-29.3%
1.1.3. Return on Equity

Shows how efficient Bionano is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • -45.6% Return on Equity means Bionano generated $-0.46 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bionano Genomics Inc:

  • The MRQ is -45.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -43.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.6%TTM-43.6%-2.0%
TTM-43.6%YOY-11.9%-31.7%
TTM-43.6%5Y-42.0%-1.6%
5Y-42.0%10Y-32.3%-9.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.6%2.3%-47.9%
TTM-43.6%2.6%-46.2%
YOY-11.9%3.1%-15.0%
5Y-42.0%3.2%-45.2%
10Y-32.3%3.0%-35.3%

1.2. Operating Efficiency of Bionano Genomics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Bionano is operating .

  • Measures how much profit Bionano makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of -186.9% means the company generated $-1.87  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bionano Genomics Inc:

  • The MRQ is -186.9%. The company is operating very inefficient. -2
  • The TTM is -380.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-186.9%TTM-380.7%+193.8%
TTM-380.7%YOY-477.2%+96.5%
TTM-380.7%5Y-425.8%+45.1%
5Y-425.8%10Y-365.4%-60.4%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-186.9%7.9%-194.8%
TTM-380.7%6.4%-387.1%
YOY-477.2%10.7%-487.9%
5Y-425.8%10.0%-435.8%
10Y-365.4%8.4%-373.8%
1.2.2. Operating Ratio

Measures how efficient Bionano is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 2.87 means that the operating costs are $2.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bionano Genomics Inc:

  • The MRQ is 2.869. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.840. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.869TTM4.840-1.971
TTM4.840YOY5.772-0.932
TTM4.8405Y5.217-0.378
5Y5.21710Y4.629+0.589
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8691.099+1.770
TTM4.8401.149+3.691
YOY5.7721.109+4.663
5Y5.2171.101+4.116
10Y4.6291.055+3.574

1.3. Liquidity of Bionano Genomics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Bionano is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.40 means the company has $1.40 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.401. The company is just able to pay all its short-term debts.
  • The TTM is 2.850. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.401TTM2.850-1.449
TTM2.850YOY7.909-5.059
TTM2.8505Y8.967-6.117
5Y8.96710Y6.635+2.332
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4012.385-0.984
TTM2.8502.589+0.261
YOY7.9092.582+5.327
5Y8.9672.635+6.332
10Y6.6352.614+4.021
1.3.2. Quick Ratio

Measures if Bionano is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.60 means the company can pay off $1.60 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.603. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.401. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.603TTM3.401-1.797
TTM3.401YOY12.822-9.422
TTM3.4015Y10.796-7.396
5Y10.79610Y7.805+2.991
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6031.165+0.438
TTM3.4011.172+2.229
YOY12.8221.283+11.539
5Y10.7961.392+9.404
10Y7.8051.477+6.328

1.4. Solvency of Bionano Genomics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Bionano assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bionano to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.55 means that Bionano assets are financed with 55.2% credit (debt) and the remaining percentage (100% - 55.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bionano Genomics Inc:

  • The MRQ is 0.552. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.328. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.552TTM0.328+0.223
TTM0.328YOY0.135+0.194
TTM0.3285Y0.464-0.136
5Y0.46410Y1.010-0.545
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5520.353+0.199
TTM0.3280.355-0.027
YOY0.1350.358-0.223
5Y0.4640.362+0.102
10Y1.0100.369+0.641
1.4.2. Debt to Equity Ratio

Measures if Bionano is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 123.0% means that company has $1.23 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bionano Genomics Inc:

  • The MRQ is 1.230. The company is able to pay all its debts with equity. +1
  • The TTM is 0.571. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.230TTM0.571+0.659
TTM0.571YOY0.158+0.413
TTM0.5715Y1.039-0.468
5Y1.03910Y0.802+0.238
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2300.541+0.689
TTM0.5710.545+0.026
YOY0.1580.529-0.371
5Y1.0390.640+0.399
10Y0.8020.665+0.137

2. Market Valuation of Bionano Genomics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bionano generates.

  • Above 15 is considered overpriced but always compare Bionano to the Medical Instruments & Supplies industry mean.
  • A PE ratio of -0.59 means the investor is paying $-0.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bionano Genomics Inc:

  • The EOD is -0.346. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.589. Based on the earnings, the company is expensive. -2
  • The TTM is -0.395. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.346MRQ-0.589+0.243
MRQ-0.589TTM-0.395-0.194
TTM-0.395YOY-0.767+0.372
TTM-0.3955Y-2.401+2.006
5Y-2.40110Y-2.803+0.403
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.34617.153-17.499
MRQ-0.58918.041-18.630
TTM-0.39519.435-19.830
YOY-0.76720.661-21.428
5Y-2.40121.526-23.927
10Y-2.80327.509-30.312
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bionano Genomics Inc:

  • The EOD is -0.433. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.737. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.749. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.433MRQ-0.737+0.304
MRQ-0.737TTM-0.749+0.012
TTM-0.749YOY-0.776+0.027
TTM-0.7495Y-2.648+1.899
5Y-2.64810Y-3.031+0.383
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.43310.417-10.850
MRQ-0.73710.581-11.318
TTM-0.7491.298-2.047
YOY-0.7764.650-5.426
5Y-2.6484.114-6.762
10Y-3.0310.108-3.139
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Bionano is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 1.08 means the investor is paying $1.08 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bionano Genomics Inc:

  • The EOD is 0.631. Based on the equity, the company is cheap. +2
  • The MRQ is 1.075. Based on the equity, the company is underpriced. +1
  • The TTM is 0.721. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.631MRQ1.075-0.444
MRQ1.075TTM0.721+0.354
TTM0.721YOY0.348+0.373
TTM0.7215Y-1.561+2.283
5Y-1.56110Y0.884-2.445
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD0.6312.531-1.900
MRQ1.0752.733-1.658
TTM0.7212.706-1.985
YOY0.3483.244-2.896
5Y-1.5613.824-5.385
10Y0.8844.219-3.335
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bionano Genomics Inc.

3.1. Institutions holding Bionano Genomics Inc

Institutions are holding 11.373% of the shares of Bionano Genomics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc3.46230.0001189364540002226.782
2023-12-31GMT Capital Corp0.96950.0377530254-6-0.0011
2023-12-31Renaissance Technologies Corp0.94020.00155142305142300
2023-12-31BlackRock Inc0.9240505360-69936-12.1565
2023-12-31Two Sigma Investments LLC0.74490.00184074094074090
2023-12-31Geode Capital Management, LLC0.68890.00013768023478110.1693
2023-12-31Millennium Management LLC0.35920.0002196434102065.4804
2023-12-31State Street Corporation0.20840113988-260999-69.6021
2023-12-31Quadrature Capital LLP0.20340.00391112661112660
2023-12-31Northern Trust Corp0.201601102693483446.1775
2023-12-31Dimensional Fund Advisors, Inc.0.17440.000195367-213986-69.1721
2023-12-31GSA Capital Partners LLP0.15890.013886902869020
2023-12-31Morgan Stanley - Brokerage Accounts0.15040822731688825.8286
2023-12-31Archford Capital Strategies, LLC0.12720.024169564-31463-31.1432
2023-12-31Engineers Gate Manager LP0.11010.003360234602340
2023-12-31FMR Inc0.097905355931933147.6602
2023-12-31TWO SIGMA SECURITIES, LLC0.09040.000949418494180
2023-12-31Susquehanna International Group, LLP0.0768042014-103530-71.1331
2023-12-31Headlands Technologies LLC0.06960.021438048380480
2023-12-31Inspire Advisors, LLC0.06670.010436461-3134-7.9151
Total 9.82480.11935373497+1113117+20.7%

3.2. Funds holding Bionano Genomics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.22850.0001121885100
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.92390.000650529200
2023-08-17MUAM Nanotechnology Related Eq Idx MF0.64735.412354051198586127.7368
2024-01-31Fidelity Extended Market Index0.40090.000721926100
2023-06-30Sygnia 4th Industrial Revolution Gl Eq B0.02530.0514138223-100177-42.0206
2024-02-29Vanguard Health Care ETF0.21660.00071184415760.4887
2023-12-31BlackRock Extended Equity Market K0.19140.00141046994396572.3894
2024-01-31Fidelity Total Market Index0.14840.0001811633115562.3
2023-09-30BlackRock Extended Mkt Composite0.1270.00156947610.0014
2024-01-31Fidelity Series Total Market Index0.09390.000151348658714.7159
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07460.00124081300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05990.001232779620.1895
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05860.0013203800
2023-12-31Northern Trust Extended Eq Market Idx0.05860.0013203800
2023-12-31T. Rowe Price U.S. Equities Tr0.05750.00063147020500186.8733
2024-02-29Dimensional US Core Equity 2 ETF0.05670.00023099600
2024-01-31Schwab Total Stock Market Index0.05120.00022799000
2024-02-29Vanguard Balanced Index Inv0.04060.00012220000
2024-02-29Invesco FTSE RAFI US 1500 Small-Mid ETF0.04040.00122208500
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03630.00011983600
Total 5.53765.47543153050+201255+6.4%

3.3. Insider Transactions

Insiders are holding 0.476% of the shares of Bionano Genomics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-13Hannah MamuszkaBUY65787.6
2023-05-16R. Erik HolmlinBUY15006.4
2023-05-12Christopher P StewartBUY50006.7

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Bionano Genomics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.418-0.700+68%-0.401-4%0.079-631%0.061-789%
Book Value Per Share--1.7583.023-42%5.152-66%2.951-40%1.945-10%
Current Ratio--1.4012.850-51%7.909-82%8.967-84%6.635-79%
Debt To Asset Ratio--0.5520.328+68%0.135+309%0.464+19%1.010-45%
Debt To Equity Ratio--1.2300.571+115%0.158+681%1.039+18%0.802+53%
Dividend Per Share----0%-0%-0%-0%
Eps---0.802-1.063+32%-0.606-24%-0.465-42%-0.359-55%
Free Cash Flow Per Share---0.641-0.601-6%-0.586-9%-0.362-43%-0.292-54%
Free Cash Flow To Equity Per Share--0.694-0.060+109%-0.480+169%0.159+337%0.117+494%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---45.676--------
Intrinsic Value_10Y_min---38.649--------
Intrinsic Value_1Y_max---2.401--------
Intrinsic Value_1Y_min---2.357--------
Intrinsic Value_3Y_max---8.873--------
Intrinsic Value_3Y_min---8.437--------
Intrinsic Value_5Y_max---17.344--------
Intrinsic Value_5Y_min---15.955--------
Market Cap60710340.000-70%103371660.00090792040.000+14%99132875.000+4%140166775.030-26%121567599.400-15%
Net Profit Margin---4.094-6.418+57%-4.798+17%-4.872+19%-4.034-1%
Operating Margin---1.869-3.807+104%-4.772+155%-4.258+128%-3.654+96%
Operating Ratio--2.8694.840-41%5.772-50%5.217-45%4.629-38%
Pb Ratio0.631-70%1.0750.721+49%0.348+208%-1.561+245%0.884+22%
Pe Ratio-0.346+41%-0.589-0.395-33%-0.767+30%-2.401+308%-2.803+376%
Price Per Share1.110-70%1.8901.660+14%1.813+4%2.563-26%2.223-15%
Price To Free Cash Flow Ratio-0.433+41%-0.737-0.749+2%-0.776+5%-2.648+259%-3.031+311%
Price To Total Gains Ratio-2.658+41%-4.526-2.910-36%-11.054+144%-12.397+174%-13.553+199%
Quick Ratio--1.6033.401-53%12.822-87%10.796-85%7.805-79%
Return On Assets---0.205-0.273+34%-0.103-50%-0.208+2%-0.277+35%
Return On Equity---0.456-0.436-4%-0.119-74%-0.420-8%-0.323-29%
Total Gains Per Share---0.418-0.700+68%-0.401-4%0.079-631%0.061-789%
Usd Book Value--96157000.000165349750.000-42%281764750.000-66%161391098.500-40%106355230.931-10%
Usd Book Value Change Per Share---0.418-0.700+68%-0.401-4%0.079-631%0.061-789%
Usd Book Value Per Share--1.7583.023-42%5.152-66%2.951-40%1.945-10%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.802-1.063+32%-0.606-24%-0.465-42%-0.359-55%
Usd Free Cash Flow---35045000.000-32848250.000-6%-32029500.000-9%-19807336.100-43%-15969112.793-54%
Usd Free Cash Flow Per Share---0.641-0.601-6%-0.586-9%-0.362-43%-0.292-54%
Usd Free Cash Flow To Equity Per Share--0.694-0.060+109%-0.480+169%0.159+337%0.117+494%
Usd Market Cap60710340.000-70%103371660.00090792040.000+14%99132875.000+4%140166775.030-26%121567599.400-15%
Usd Price Per Share1.110-70%1.8901.660+14%1.813+4%2.563-26%2.223-15%
Usd Profit---43891000.000-58123250.000+32%-33149000.000-24%-25422281.550-42%-19626069.069-55%
Usd Revenue--10721000.0009029000.000+19%6950500.000+54%5026606.700+113%4442445.241+141%
Usd Total Gains Per Share---0.418-0.700+68%-0.401-4%0.079-631%0.061-789%
 EOD+3 -5MRQTTM+18 -15YOY+10 -235Y+9 -2510Y+9 -25

4.2. Fundamental Score

Let's check the fundamental score of Bionano Genomics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.346
Price to Book Ratio (EOD)Between0-10.631
Net Profit Margin (MRQ)Greater than0-4.094
Operating Margin (MRQ)Greater than0-1.869
Quick Ratio (MRQ)Greater than11.603
Current Ratio (MRQ)Greater than11.401
Debt to Asset Ratio (MRQ)Less than10.552
Debt to Equity Ratio (MRQ)Less than11.230
Return on Equity (MRQ)Greater than0.15-0.456
Return on Assets (MRQ)Greater than0.05-0.205
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Bionano Genomics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.873
Ma 20Greater thanMa 501.096
Ma 50Greater thanMa 1001.167
Ma 100Greater thanMa 2001.368
OpenGreater thanClose1.100
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -1,124459-665355-310217-9311623
Tax Provision  1,805-1,77926733639-75-36
Net Interest Income  695-67628-1361544659-4,368-3,709
Income Tax Expense  1,805-1,77926733639-75-36



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets214,404
Total Liabilities118,247
Total Stockholder Equity96,157
 As reported
Total Liabilities 118,247
Total Stockholder Equity+ 96,157
Total Assets = 214,404

Assets

Total Assets214,404
Total Current Assets140,118
Long-term Assets74,286
Total Current Assets
Cash And Cash Equivalents 53,065
Short-term Investments 48,823
Net Receivables 9,661
Inventory 22,893
Other Current Assets 5,676
Total Current Assets  (as reported)140,118
Total Current Assets  (calculated)140,118
+/-0
Long-term Assets
Property Plant Equipment 32,481
Intangible Assets 33,972
Long-term Assets Other 7,431
Long-term Assets  (as reported)74,286
Long-term Assets  (calculated)73,884
+/- 402

Liabilities & Shareholders' Equity

Total Current Liabilities100,028
Long-term Liabilities18,219
Total Stockholder Equity96,157
Total Current Liabilities
Short-term Debt 80,772
Short Long Term Debt 69,803
Accounts payable 10,384
Other Current Liabilities 8,089
Total Current Liabilities  (as reported)100,028
Total Current Liabilities  (calculated)169,048
+/- 69,020
Long-term Liabilities
Capital Lease Obligations 9,610
Long-term Liabilities Other 10,890
Long-term Liabilities  (as reported)18,219
Long-term Liabilities  (calculated)20,500
+/- 2,281
Total Stockholder Equity
Common Stock5
Retained Earnings -581,208
Accumulated Other Comprehensive Income 23
Other Stockholders Equity 677,337
Total Stockholder Equity (as reported)96,157
Total Stockholder Equity (calculated)96,157
+/-0
Other
Capital Stock5
Cash and Short Term Investments 101,888
Common Stock Shares Outstanding 45,752
Current Deferred Revenue783
Liabilities and Stockholders Equity 214,404
Net Debt 34,882
Net Invested Capital 165,960
Net Working Capital 40,090
Property Plant and Equipment Gross 51,558
Short Long Term Debt Total 87,947



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
14,788
0
0
0
10,145
16,462
18,094
30,670
24,802
29,551
25,211
19,207
30,208
19,102
27,204
41,396
60,450
384,861
356,809
359,657
377,100
348,211
321,552
323,698
307,502
292,151
271,381
181,904
214,404
214,404181,904271,381292,151307,502323,698321,552348,211377,100359,657356,809384,86160,45041,39627,20419,10230,20819,20725,21129,55124,80230,67018,09416,46210,14500014,788
   > Total Current Assets 
10,736
0
0
0
7,139
13,848
15,654
28,621
23,025
28,014
23,932
17,839
28,258
16,982
24,654
29,240
46,789
370,251
341,965
342,047
272,414
242,360
216,288
218,197
157,298
142,557
122,575
104,537
140,118
140,118104,537122,575142,557157,298218,197216,288242,360272,414342,047341,965370,25146,78929,24024,65416,98228,25817,83923,93228,01423,02528,62115,65413,8487,13900010,736
       Cash And Cash Equivalents 
5,250
0
0
0
1,022
7,553
7,624
20,657
16,523
20,830
15,295
8,225
17,311
8,144
17,194
18,867
38,449
362,057
332,554
140,736
24,571
24,048
27,159
28,166
5,091
4,104
14,856
34,568
53,065
53,06534,56814,8564,1045,09128,16627,15924,04824,571140,736332,554362,05738,44918,86717,1948,14417,3118,22515,29520,83016,52320,6577,6247,5531,0220005,250
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185,333
226,041
192,420
160,178
152,024
108,095
91,704
62,206
29,014
48,823
48,82329,01462,20691,704108,095152,024160,178192,420226,041185,3330000000000000000000
       Net Receivables 
1,847
0
0
0
3,352
2,536
2,886
4,001
4,514
4,057
4,984
6,001
6,334
4,115
3,249
3,860
2,775
1,992
2,838
2,996
4,934
5,514
4,851
5,829
7,022
6,780
7,613
8,669
9,661
9,6618,6697,6136,7807,0225,8294,8515,5144,9342,9962,8381,9922,7753,8603,2494,1156,3346,0014,9844,0574,5144,0012,8862,5363,3520001,847
       Inventory 
1,797
0
0
0
1,694
2,014
1,973
2,615
1,069
1,406
3,022
2,595
3,444
3,611
3,290
4,593
3,316
3,036
4,890
9,020
12,387
16,268
20,591
25,046
29,761
33,113
32,453
26,429
22,893
22,89326,42932,45333,11329,76125,04620,59116,26812,3879,0204,8903,0363,3164,5933,2903,6113,4442,5953,0221,4061,0692,6151,9732,0141,6940001,797
       Other Current Assets 
1,842
0
0
0
579
536
615
1,099
920
1,374
466
695
1,169
1,112
921
1,920
2,250
3,166
1,683
3,962
4,481
4,110
3,509
7,132
7,329
6,856
5,447
5,857
5,676
5,6765,8575,4476,8567,3297,1323,5094,1104,4813,9621,6833,1662,2501,9209211,1121,1696954661,3749201,0996155365790001,842
   > Long-term Assets 
0
0
0
0
3,006
2,614
2,441
2,049
1,777
1,537
1,279
1,368
1,950
2,120
2,550
12,156
13,660
14,610
14,844
17,610
104,686
105,851
105,264
105,501
150,204
149,594
148,806
77,367
74,286
74,28677,367148,806149,594150,204105,501105,264105,851104,68617,61014,84414,61013,66012,1562,5502,1201,9501,3681,2791,5371,7772,0492,4412,6143,0060000
       Property Plant Equipment 
4,052
0
0
0
3,006
2,614
2,441
2,049
1,777
1,537
1,279
1,368
1,950
2,120
2,550
3,635
4,910
5,806
6,084
8,554
20,935
23,375
24,164
25,648
28,958
29,769
30,566
30,991
32,481
32,48130,99130,56629,76928,95825,64824,16423,37520,9358,5546,0845,8064,9103,6352,5502,1201,9501,3681,2791,5371,7772,0492,4412,6143,0060004,052
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,941
7,173
7,173
7,173
7,173
56,160
56,254
56,254
56,466
77,289
77,289
77,281
0
0
0077,28177,28977,28956,46656,25456,25456,1607,1737,1737,1737,1736,941000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,580
1,475
1,396
1,317
1,238
26,842
25,424
24,005
22,585
41,143
39,351
37,559
35,766
33,972
33,97235,76637,55939,35141,14322,58524,00525,42426,8421,2381,3171,3961,4751,580000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103
235
270
645
749
798
841
802
2,814
0
3,400
10,610
0
010,6103,40002,8148028417987496452702351030000000000000000
> Total Liabilities 
16,630
0
0
0
60,372
70,482
75,372
15,435
14,665
23,681
26,556
26,586
26,640
23,315
21,367
26,720
25,367
22,143
10,943
18,092
39,982
37,026
36,818
41,956
58,104
60,664
56,625
62,905
118,247
118,24762,90556,62560,66458,10441,95636,81837,02639,98218,09210,94322,14325,36726,72021,36723,31526,64026,58626,55623,68114,66515,43575,37270,48260,37200016,630
   > Total Current Liabilities 
9,364
0
0
0
16,652
26,854
22,427
5,515
4,523
4,714
7,541
7,437
26,305
23,188
19,508
24,782
8,944
7,169
10,730
17,702
21,840
18,659
27,908
33,500
35,884
38,135
33,499
40,194
100,028
100,02840,19433,49938,13535,88433,50027,90818,65921,84017,70210,7307,1698,94424,78219,50823,18826,3057,4377,5414,7144,5235,51522,42726,85416,6520009,364
       Short-term Debt 
587
6,633
0
0
6,730
20,011
14,330
0
0
0
800
953
20,023
16,969
13,938
14,239
562
14,866
0
0
1,766
2,026
2,049
2,072
2,545
2,517
2,293
2,462
80,772
80,7722,4622,2932,5172,5452,0722,0492,0261,7660014,86656214,23913,93816,96920,02395380000014,33020,0116,730006,633587
       Short Long Term Debt 
587
6,633
0
0
6,730
6,681
23,286
0
0
0
800
953
20,085
16,969
13,938
14,239
0
0
0
0
0
0
0
0
0
0
0
0
69,803
69,80300000000000014,23913,93816,96920,08595380000023,2866,6816,730006,633587
       Accounts payable 
792
0
0
0
2,303
936
1,752
2,364
1,352
871
3,618
2,634
2,699
3,176
2,850
5,665
2,930
2,209
3,745
7,875
9,696
6,590
7,695
9,407
12,534
15,780
11,912
15,369
10,384
10,38415,36911,91215,78012,5349,4077,6956,5909,6967,8753,7452,2092,9305,6652,8503,1762,6992,6343,6188711,3522,3641,7529362,303000792
       Other Current Liabilities 
7,985
0
0
0
7,408
5,741
6,104
2,815
2,900
3,629
2,702
3,432
3,225
2,725
2,431
4,466
5,037
4,659
6,540
9,416
9,694
7,957
16,911
21,039
19,934
18,711
18,299
21,535
8,089
8,08921,53518,29918,71119,93421,03916,9117,9579,6949,4166,5404,6595,0374,4662,4312,7253,2253,4322,7023,6292,9002,8156,1045,7417,4080007,985
   > Long-term Liabilities 
0
0
0
0
43,720
43,628
52,945
9,920
10,142
18,968
19,015
19,149
335
127
1,859
1,938
16,423
14,974
213
390
18,142
18,367
8,910
8,456
22,220
22,529
23,126
22,711
18,219
18,21922,71123,12622,52922,2208,4568,91018,36718,14239021314,97416,4231,9381,85912733519,14919,01518,96810,1429,92052,94543,62843,7200000
       Long term Debt Total 
0
0
0
0
0
0
0
9,008
9,029
18,376
18,622
18,777
0
0
1,775
1,775
16,326
0
0
0
0
0
0
0
0
0
0
0
0
00000000000016,3261,7751,7750018,77718,62218,3769,0299,0080000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,696
11,115
10,756
10,392
11,668
11,172
10,663
10,142
9,610
9,61010,14210,66311,17211,66810,39210,75611,11510,69600000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
767
808
287
174
147
44
127
84
163
0
108
213
390
17,996
18,367
8,910
8,456
22,093
22,529
14,570
14,880
10,890
10,89014,88014,57022,52922,0938,4568,91018,36717,996390213108016384127441471742878087670000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
145
304
304
0
0
183
0
0
0
98
0
0
0
146
0
0
0
127
0
0
0
0
000012700014600098000183003043041450000000
> Total Stockholder Equity
-27,259
-27,259
0
0
-50,227
-54,020
-57,278
15,235
10,137
5,870
-1,345
-7,379
3,614
-4,213
5,837
14,676
35,082
362,718
345,866
341,565
337,118
311,185
284,734
281,742
249,398
231,487
214,756
118,999
96,157
96,157118,999214,756231,487249,398281,742284,734311,185337,118341,565345,866362,71835,08214,6765,837-4,2133,614-7,379-1,3455,87010,13715,235-57,278-54,020-50,22700-27,259-27,259
   Common Stock
0
0
0
0
0
0
0
1
1
1
1
1
3
3
9
15
19
28
28
28
29
29
29
30
30
31
3
3
5
5333130302929292828281915933111110000000
   Retained Earnings -581,208-537,317-424,751-385,839-348,715-310,038-278,229-246,071-216,119-193,170-172,417-153,631-143,684-131,953-121,161-113,087-102,577-94,677-88,279-80,614-72,762-66,351-61,425-58,113-54,266000-30,901
   Capital Surplus 
0
0
0
0
0
0
0
81,585
82,899
86,483
86,933
87,297
106,188
108,871
126,989
146,614
178,747
516,321
518,255
534,823
553,747
558,864
564,852
593,572
599,207
617,960
639,814
0
0
00639,814617,960599,207593,572564,852558,864553,747534,823518,255516,321178,747146,614126,989108,871106,18887,29786,93386,48382,89981,5850000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
7,960
8,406
8,795
86,624
88,061
62,364
92,632
93,275
112,461
108,871
126,989
146,614
178,747
516,321
518,255
534,823
553,747
558,864
564,852
593,572
599,207
617,960
639,814
656,406
677,337
677,337656,406639,814617,960599,207593,572564,852558,864553,747534,823518,255516,321178,747146,614126,989108,871112,46193,27592,63262,36488,06186,6248,7958,4067,9600000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue36,116
Cost of Revenue-26,550
Gross Profit9,5669,566
 
Operating Income (+$)
Gross Profit9,566
Operating Expense-148,993
Operating Income-139,427-139,427
 
Operating Expense (+$)
Research Development54,032
Selling General Administrative93,499
Selling And Marketing Expenses0
Operating Expense148,993147,531
 
Net Interest Income (+$)
Interest Income3,311
Interest Expense-5,119
Other Finance Cost-0
Net Interest Income-1,808
 
Pretax Income (+$)
Operating Income-139,427
Net Interest Income-1,808
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-232,431-46,423
EBIT - interestExpense = -144,546
-232,431
-227,374
Interest Expense5,119
Earnings Before Interest and Taxes (EBIT)-139,427-227,312
Earnings Before Interest and Taxes (EBITDA)-125,719
 
After tax Income (+$)
Income Before Tax-232,431
Tax Provision-62
Net Income From Continuing Ops-232,493-232,493
Net Income-232,493
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses175,543
Total Other Income/Expenses Net-93,0041,808
 

Technical Analysis of Bionano
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bionano. The general trend of Bionano is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bionano's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bionano Genomics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.11 < 1.34 < 1.35.

The bearish price targets are: 1 > 1.

Tweet this
Bionano Genomics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bionano Genomics Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bionano Genomics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bionano Genomics Inc. The current macd is -0.04138299.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionano price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Bionano. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Bionano price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Bionano Genomics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBionano Genomics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bionano Genomics Inc. The current adx is 12.63.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Bionano shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Bionano Genomics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bionano Genomics Inc. The current sar is 1.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bionano Genomics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bionano Genomics Inc. The current rsi is 48.87. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Bionano Genomics Inc Daily Relative Strength Index (RSI) ChartBionano Genomics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bionano Genomics Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bionano price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Bionano Genomics Inc Daily Stochastic Oscillator ChartBionano Genomics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bionano Genomics Inc. The current cci is 21.87.

Bionano Genomics Inc Daily Commodity Channel Index (CCI) ChartBionano Genomics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bionano Genomics Inc. The current cmo is 11.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bionano Genomics Inc Daily Chande Momentum Oscillator (CMO) ChartBionano Genomics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bionano Genomics Inc. The current willr is -42.10526316.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Bionano is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Bionano Genomics Inc Daily Williams %R ChartBionano Genomics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bionano Genomics Inc.

Bionano Genomics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bionano Genomics Inc. The current atr is 0.07689359.

Bionano Genomics Inc Daily Average True Range (ATR) ChartBionano Genomics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bionano Genomics Inc. The current obv is -49,167,672.

Bionano Genomics Inc Daily On-Balance Volume (OBV) ChartBionano Genomics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bionano Genomics Inc. The current mfi is 47.02.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Bionano Genomics Inc Daily Money Flow Index (MFI) ChartBionano Genomics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bionano Genomics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Bionano Genomics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bionano Genomics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.873
Ma 20Greater thanMa 501.096
Ma 50Greater thanMa 1001.167
Ma 100Greater thanMa 2001.368
OpenGreater thanClose1.100
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Bionano with someone you think should read this too:
  • Are you bullish or bearish on Bionano? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bionano? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bionano Genomics Inc

I send you an email if I find something interesting about Bionano Genomics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bionano Genomics Inc.

Receive notifications about Bionano Genomics Inc in your mailbox!